- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03777800
Body Therapy for War Veterans With Post Traumatic Stress Disorder (PTSD)
Body Therapy for War Veterans With Post Traumatic Stress Disorder (PTSD): A Combined Randomized Controlled Trial (RCT) and Qualitative Study.
The present study is a randomized, controlled trial that compares a certain type of body therapy, called ManuVision, to treatment as usual (TAU) in war veterans with posttraumatic stress disorder (PTSD). The purpose of the study is to determine whether participation in the body therapy treatment by war veterans who have PTSD, will reduce symptoms of PTSD and depression, and improve quality of life, function level and body awareness.
Study hypotheses state that the ManuVision approach, compared to the treatment as usual, will be more effective at reducing the PTSD symptoms experienced by veterans because it will help the veterans learning to become aware of, accept the PTSD symptoms, reading their own emotional state and gain body awareness and subsequently have emotional control and improved coping mechanism when PTSD symptoms arise. The awareness, accept and improved coping mechanisms means that the nervous system is not under the same pressure and that PTSD symptoms therefore may be reduced.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background: A sizable proportion of soldiers involved in military missions are experiencing mental health and adjustment problems on their return, including PTSD. PTSD is both a psychological and a physical condition, which occurs as a post-reaction to one or more traumatic experiences. The symptoms include aggressive behaviour, difficulty sleeping, tiredness, anxiety, and social isolation, and many sufferers develop depression, and the war veterans are at a higher risk of suicide. Physiologically, people with PTSD experience an activation of their sympathetic nervous system, whereby the stress hormones adrenalin and cortisol are released, the heart rate increases, the blood pressure rises, and the body is geared toward a 'fight or flight' response. A major challenge for veterans with PTSD is emotional control and problems with reading their own and others' emotional state.
This study will provide a certain type of body therapy, called ManuVision, to war veterans with PTSD. ManuVision is a Danish developed body therapy working with direct physical treatment of the body and through this approach with the client's psychosocial resources. There are conversations during and before treatment, as appropriate, and trust is intentionally built from the first meeting through eye contact and open breathing on behalf of the ManuVision therapist. The treatment is based on the understanding that chock, trauma and stress are stored in the body blocking the muscles and breathing and affecting the nerve system.
The intervention in this project entails individual courses of body therapy including 24 treatment sessions over 6 months for veterans with PTSD, plus recommended daily meditation at home.
The study goals are to:
- Investigate how the body therapy treatment is implemented, and how the participants experience the treatment, respond to the treatment and which transformations participants experience in the everyday life (a process evaluation by qualitative methods).
- Compare the body therapy treatment with treatment as usual (TAU). Symptoms of PTSD, depression, function level, quality of life, and body awareness will be examined at pre-treatment, midway during the treatment period, post-treatment and, if possible, at follow-up to determine if symptoms change over time (an effect evaluation by quantitative methods).
The research questions are as follows:
A. How is the treatment implemented, how do the participants experience and respond to the treatment, and what characterizes the interaction between veteran and practitioner? B. In which ways do the veterans experience transformations, e.g. in terms of their body, feelings, social relations, everyday lives, quality of life, and handling their PTSD symptoms? C. What is the effect of the intervention on PTSD symptoms, quality of life, function level, depression and body awareness? D. Are there better outcomes for participants who received more treatment (i.e., number of treatment sessions)?
In order to answer the research questions A and B we will use participant observation, qualitative interviews, and focus group interviews with veterans, family members and practitioners.
In order to answer the research question C concerning the intervention's effect, appropriate statistical methods (e.g., Repeated measures ANOVA) will be used to analyse the differences between the intervention and the control group based on validated questionnaires.
Finally, a dose-response analysis is carried out (D) based on the practitioners' registered number of treatment sessions. This will support and refine the effect estimations.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Nanna Ahlmark, PhD
- Phone Number: +4565 50 78 15
- Email: naah@niph.dk
Study Contact Backup
- Name: Susan Andersen, PhD
- Phone Number: +4565507816
- Email: sua@niph.dk
Study Locations
-
-
-
Copenhagen, Denmark, 2100
- Military Psychiatric Center, Copenhagen University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Veterans
- Meet criteria for clinical PTSD or subclinical PTSD assessed by The Structured Clinical Interview for DSM-IV (SCID)
- Demonstrate understanding of informed consent and normal cognitive skills
Exclusion Criteria:
- Current substance dependence (alcohol or drugs)
- Severe mental disorders such as schizophrenia, Bipolar I or II disorder, or current psychiatric conditions such as psychosis or mania
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Body Therapy
Participants in the intervention condition will be assigned to a 6-month body therapy treatment focused on 24 individual body treatments including conversations and direct physical treatment of the body combined with home-based daily practice of meditation.
|
Body therapy involving direct physical treatments, conversations, breathing exercises and relaxation in the sessions. Moreover, the participants are taught how to practice vipassana or awareness meditation every day at home. The body therapist works directly with the muscle armour and the treatment sessions have focus on creating a safe environment and enabling cognitive realisation and awareness of symptoms. Each participant is assigned a practitioner who acts as contact person and 'lifeline'. Furthermore, a coordinator is assigned in ManuVision who will also act as contact person when needed for the veterans. This provides peace of mind, trust, and ensures retention. The coordinator or the practitioner follows up on the veteran's progress prior to each session.
Other Names:
|
Active Comparator: Treatment As usual
Participants in the control condition will be offered treatment as usual, which is psychiatric medication and/or individual psychotherapy as deemed relevant by the psychiatrist.
|
Standard treatment
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Self-reported PTSD symptoms by the PTSD checklist - military version (PCL-M)
Time Frame: Change from baseline to midway (approximately 3 months), post-treatment (approximately 6 months) and, if possible, follow-up (12 months)
|
The PTSD checklist contains 17 items corresponding to the DSM-IV criteria for PTSD.
Past month symptom severity is indicated using a 5 point scale.
Higher scores represent greater severity.
|
Change from baseline to midway (approximately 3 months), post-treatment (approximately 6 months) and, if possible, follow-up (12 months)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Self-reported depression symptoms as measured by the Major Depression Inventory (MDI)
Time Frame: Change from baseline to midway (approximately 3 months), post-treatment (approximately 6 months) and, if possible, follow-up (12 months)
|
The severity of depression is measured over the last 2 weeks in the form of a Likert scale at which the frequency of each symptom can be indicated from 0 (at no time) to 5 (all the time).
Score range is from 0 (no depression) to 50 (extreme depression).
|
Change from baseline to midway (approximately 3 months), post-treatment (approximately 6 months) and, if possible, follow-up (12 months)
|
Self-reported quality of life using the World Health Organization Five Well-Being Index (WHO-5)
Time Frame: Change from baseline to midway (approximately 3 months), post-treatment (approximately 6 months) and, if possible, follow-up (12 months)
|
Each of the five items indicates current positive wellbeing during the previous two weeks from 0 (at no time) to 5 (all of the time).
|
Change from baseline to midway (approximately 3 months), post-treatment (approximately 6 months) and, if possible, follow-up (12 months)
|
Function level using the Sheehan Disability Scale (SDS)
Time Frame: Change from baseline to midway (approximately 3 months), post-treatment (approximately 6 months) and, if possible, follow-up (12 months)
|
A self-administered rating scale measuring functional impairment with regard to family, work and social network using three visual analogue scales.
|
Change from baseline to midway (approximately 3 months), post-treatment (approximately 6 months) and, if possible, follow-up (12 months)
|
Self-reported body awareness using the Multidimensional Assessment of Interceptive Awareness (MAIA) Questionnaire
Time Frame: Change from baseline to midway (approximately 3 months), post-treatment (approximately 6 months) and, if possible, follow-up (12 months)
|
MAIA contains 32 items.
The items are organized into eight subscales: (1) Noticing: the awareness of body sensations; (2) Not-Distracting: the tendency to ignore or distract oneself from sensations of pain or discomfort; (3) Not-Worrying: emotional distress or worry with sensations of pain or discomfort; (4) Attention Regulation: the ability to sustain and control attention to body sensation; (5) Emotional Awareness: the awareness of the connection between body sensations and emotional states; (6) Self-Regulation: the ability to regulate psychological distress by attention to body sensations; (7) Body Listening: actively listening to the body for insight; (8) Trusting: experiencing one's body as safe and trustworthy.
|
Change from baseline to midway (approximately 3 months), post-treatment (approximately 6 months) and, if possible, follow-up (12 months)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Participants' responsiveness
Time Frame: Post-treatment (approximately 6 months)
|
A 3-item questionnaire with a 0-10 response scale to measure the participants' judgement of the treatment (only the intervention group)
|
Post-treatment (approximately 6 months)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Nanna Ahlmark, PhD, National Institute of Public Health, University of Southern Denmark
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 10.128
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Behavioral Symptoms
-
AccareRecruitingBehavioral Problem of Child | Behavioral DifficultiesNetherlands
-
University of AarhusInnovation Fund Denmark; TRYG Foundation; The Danish Mental Health Foundation; Aarhus...CompletedDepressive Symptoms | Anxiety Symptoms | Behavioral Problem | School AbsenteeismDenmark
-
Universidade do PortoCentro Hospitalar Universitário de São João, E.P.E.; Centro de Investigação... and other collaboratorsCompletedAnxiety | Behavioral Problem of ChildPortugal
-
Central Hospital, Nancy, FranceMarie MANGEOT- Nurse; Mahmut GUNDESLI MDCompleted
-
Fatima Jinnah Women UniversityRecruitingWell-being, Emotional and Behavioral Problems, AdolescentsPakistan
-
AccareRecruitingBrief Parent Training for Children With Behavioral Difficulties in Primary Care Settings (PAINT-POH)Behavioral DifficultiesNetherlands
-
National Taiwan University HospitalMinistry of Science and Technology, TaiwanCompleted
-
AccareRecruitingBehavioral Symptoms | Behavior Problems | Behavioral Problems | Disruptive Behavior | Problem Behaviors | Behavioral DifficultiesNetherlands
-
University of California, San FranciscoCompleted
-
New York State Psychiatric InstituteSackler FoundationTerminated
Clinical Trials on Body therapy
-
Lund UniversityVastra Gotaland RegionCompleted
-
The Hong Kong Polytechnic UniversityUnknown
-
The Hong Kong Polytechnic UniversityCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Cancer Prevention Research Institute of TexasActive, not recruitingMetastatic Renal Cell Carcinoma | Stage IV Renal Cell Cancer AJCC v8 | Malignant Neoplasms of Urinary Tract | Oligometastatic Renal Cell CarcinomaUnited States
-
University of AlbertaCompleted
-
Tel-Aviv Sourasky Medical CenterUnknownPatients Who Are in Need of Short or Long Term Rehabilitation Due to Neurological Event (Mainly Stroke) or Post Orthopedic SurgeryIsrael
-
National Human Genome Research Institute (NHGRI)Completed
-
Roswell Park Cancer InstituteCompletedLung CancerUnited States
-
University of AlbertaCompletedWellbeing | Stress, Psychological | Mind Body TherapyCanada
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityCompletedHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | Chemotherapy-Induced Peripheral NeuropathyUnited States